Octanate Lv (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a coagulation factor replacement therapy presented as a unknown/unknown for intravenous use. It treats hemophilia A in patients requiring factor replacement. GNH USA supplies Octanate Lv as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Octanate Lv is a recombinant factor VIII product that operates ​​      ​  ​  ​  ​ ​  ​                                                     ​  ​  ​ ​   ​    ​    ​           - Hemophilia A (severe): Provides clotting factor replacement to prevent or control bleeding episodes. - Hemophilia A (moderate): Supports routine prophylaxis to reduce frequency of bleeds. - Hemophilia A (surgical): Provides peri‑operational  ​  ​  ​   -  ​   ​ ​  ... ... ... ...  …  …  … …  … … …  …